Fournier, Marion http://orcid.org/0000-0001-5718-1509
Radel, Rémi
Bailly, Laurent
Pradier, Christian
Fabre, Roxane
Fuch, Alain
Mossé, Philippe
Domerego, Jean-Jacques
Gal, Jocelyn
d’Arripe-Longueville, Fabienne
Article History
Received: 28 November 2017
Accepted: 20 April 2018
First Online: 2 May 2018
Ethics approval and consent to participate
: Ethics approval for the trial was received from the National Ethics Committee for Human Research (number: 14073) and the National Drug Agency (number: 141299B-21). The regional governmental health agency also approved the various locations for the intervention (number: DOS-01115-0577-D). Participants signed consent forms to participate to the study.
: The authors declare that they have no competing interests.In the past five years, we have received no reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future.None of us holds any stocks or shares in an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future.We do not hold nor are we currently applying for any patents relating to the content of the manuscript. We have received no reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript.We have no other financial competing interests.There are no non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.